Findings from our recent study have led us to adopt the geko™ device for all ankle and hind foot fractures in our unit. We are extremely pleased with the results we are getting.
We saw the potential to help ankle fracture patients become ready for theatre sooner and thought the geko™ device might provide the answer.
Working in partnership with Firstkind, we conducted a prospective and retrospective study to investigate use of the geko™ to reduce pre-operative oedema in ankle fracture patients requiring Open Reduction Surgical Fixation (ORIF).
We fitted the geko™ device above the backslab plaster cast and measured patient tolerance and readiness to theatre, matched to a historical cohort.
The study data was statistically significant in accelerating readiness for theatre: p=0.0011.
The geko™ device is cost saving
Independent health economic analysis shows routine use the geko™ device + backslab plaster cast, to accelerate readiness to theatre, saves an average of £5692 per patient, compared to current standards of care.
2 days improvement in readiness to theatre (average).
With geko™ use, 60% of patients ready for theatre in 2 days, a 122% improvement.
Cost saving of £569 per patient (average).